JP2010515733A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010515733A5 JP2010515733A5 JP2009545577A JP2009545577A JP2010515733A5 JP 2010515733 A5 JP2010515733 A5 JP 2010515733A5 JP 2009545577 A JP2009545577 A JP 2009545577A JP 2009545577 A JP2009545577 A JP 2009545577A JP 2010515733 A5 JP2010515733 A5 JP 2010515733A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbonyl
- alkyl
- cyclo
- chroman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 78
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 36
- 125000005843 halogen group Chemical group 0.000 claims 35
- 125000006828 (C2-C7) alkoxycarbonyl group Chemical group 0.000 claims 27
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 23
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 22
- 125000001424 substituent group Chemical group 0.000 claims 21
- 150000002148 esters Chemical class 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 19
- 125000003545 alkoxy group Chemical group 0.000 claims 17
- 125000002252 acyl group Chemical group 0.000 claims 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000003118 aryl group Chemical group 0.000 claims 13
- 125000004043 oxo group Chemical group O=* 0.000 claims 13
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 12
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 10
- 125000004414 alkyl thio group Chemical group 0.000 claims 10
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000004434 sulfur atom Chemical group 0.000 claims 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- 125000000464 thioxo group Chemical group S=* 0.000 claims 7
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 6
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims 6
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 6
- -1 1-Ethyl-4-methoxy-1H-benzimidazol-6-yl Chemical group 0.000 claims 5
- 125000004423 acyloxy group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 claims 3
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims 3
- GVLRTOYGRNLSDW-UHFFFAOYSA-N 1h-pyrazolo[3,4-b]pyridine Chemical compound C1=CC=C2C=NNC2=N1 GVLRTOYGRNLSDW-UHFFFAOYSA-N 0.000 claims 3
- FKWUPVHNVKGGSD-UHFFFAOYSA-N 1h-thieno[2,3-c]pyrazole Chemical compound C1=NNC2=C1C=CS2 FKWUPVHNVKGGSD-UHFFFAOYSA-N 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- KZOWNALBTMILAP-JBMRGDGGSA-N ancitabine hydrochloride Chemical compound Cl.N=C1C=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 KZOWNALBTMILAP-JBMRGDGGSA-N 0.000 claims 3
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 3
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims 3
- UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical compound C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 claims 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims 3
- 208000032841 Bulimia Diseases 0.000 claims 2
- 206010006550 Bulimia nervosa Diseases 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 208000004930 Fatty Liver Diseases 0.000 claims 2
- 206010019708 Hepatic steatosis Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000010706 fatty liver disease Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- OEOFWVOLIASGRM-UHFFFAOYSA-N (1-cyclopropyl-4-methoxyindol-6-yl)-[6-(2H-tetrazol-5-yl)spiro[3,4-dihydrochromene-2,4'-piperidine]-1'-yl]methanone Chemical compound C1(CC1)N1C=CC2=C(C=C(C=C12)C(=O)N1CCC2(CC1)OC1=CC=C(C=C1CC2)C1=NN=NN1)OC OEOFWVOLIASGRM-UHFFFAOYSA-N 0.000 claims 1
- 125000006773 (C2-C7) alkylcarbonyl group Chemical group 0.000 claims 1
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 claims 1
- AWNDPNWXFGRJQI-UHFFFAOYSA-N 1'-(1,3-diethyl-7-methoxy-2-oxobenzimidazole-5-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C=1C(OC)=C2N(CC)C(=O)N(CC)C2=CC=1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 AWNDPNWXFGRJQI-UHFFFAOYSA-N 0.000 claims 1
- JHWHHWDHRLPXLG-UHFFFAOYSA-N 1'-(1,4-diethoxyindazole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C=1C=2N(OCC)N=CC=2C(OCC)=CC=1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 JHWHHWDHRLPXLG-UHFFFAOYSA-N 0.000 claims 1
- OAMOWQJTVYLHGK-UHFFFAOYSA-N 1'-(1,4-dimethoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C=1C=2N(OC)C=CC=2C(OC)=CC=1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 OAMOWQJTVYLHGK-UHFFFAOYSA-N 0.000 claims 1
- YPJUVNXGAKFASN-UHFFFAOYSA-N 1'-(1,4-dimethoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one;sodium Chemical compound [Na].C=1C=2N(OC)C=CC=2C(OC)=CC=1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C=1N=NNN=1 YPJUVNXGAKFASN-UHFFFAOYSA-N 0.000 claims 1
- JFAWMIWDSQSOMV-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-ethoxy-3-methylindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C(C)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 JFAWMIWDSQSOMV-UHFFFAOYSA-N 0.000 claims 1
- LPWKEJNQEJOLNF-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-ethoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=CC=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 LPWKEJNQEJOLNF-UHFFFAOYSA-N 0.000 claims 1
- OJQNMRDPSKTWSY-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-ethoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one;sodium Chemical compound [Na].C1=CC=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C3=NNN=N3)=CC=2N1C1CC1 OJQNMRDPSKTWSY-UHFFFAOYSA-N 0.000 claims 1
- MWOXXNTYIFYXJQ-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 MWOXXNTYIFYXJQ-UHFFFAOYSA-N 0.000 claims 1
- JQKVGZANRSXPOU-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 JQKVGZANRSXPOU-UHFFFAOYSA-N 0.000 claims 1
- DZCHXXJDTKQUOA-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one;sodium Chemical compound [Na].C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C3=NNN=N3)=CC=2N1C1CC1 DZCHXXJDTKQUOA-UHFFFAOYSA-N 0.000 claims 1
- AJUCBKYSAOERCP-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-6-(5-oxo-1,2-dihydro-1,2,4-triazol-3-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NC(=O)NN=3)=CC=2N1C1CC1 AJUCBKYSAOERCP-UHFFFAOYSA-N 0.000 claims 1
- VXOXUMFIISPGSV-UHFFFAOYSA-N 1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-6-(5-oxo-2h-1,2,4-oxadiazol-3-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NC(=O)ON=3)=CC=2N1C1CC1 VXOXUMFIISPGSV-UHFFFAOYSA-N 0.000 claims 1
- OYZMUGLPMDQPDV-UHFFFAOYSA-N 1'-(1-ethyl-3-methylthieno[2,3-c]pyrazole-5-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound S1C=2N(CC)N=C(C)C=2C=C1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 OYZMUGLPMDQPDV-UHFFFAOYSA-N 0.000 claims 1
- NKDMEHKUJITRJR-UHFFFAOYSA-N 1'-(1-ethyl-4-methoxyindazole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C2N(CC)N=CC2=C(OC)C=C1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 NKDMEHKUJITRJR-UHFFFAOYSA-N 0.000 claims 1
- ZMELGQVAMKHNGD-UHFFFAOYSA-N 1'-(1-ethyl-4-methoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C2N(CC)C=CC2=C(OC)C=C1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 ZMELGQVAMKHNGD-UHFFFAOYSA-N 0.000 claims 1
- AWKUNWUUMKOYCI-UHFFFAOYSA-N 1'-(1-ethyl-4-morpholin-4-ylindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C2N(CC)C=CC2=C(N2CCOCC2)C=C1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 AWKUNWUUMKOYCI-UHFFFAOYSA-N 0.000 claims 1
- BQDDEWPJPSWXRR-UHFFFAOYSA-N 1'-(2-cyclopropyl-7-ethoxy-1,3-benzoxazole-5-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound O1C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N=C1C1CC1 BQDDEWPJPSWXRR-UHFFFAOYSA-N 0.000 claims 1
- XUYLEIKOZAMWOE-UHFFFAOYSA-N 1'-(3-chloro-1-cyclopropyl-4-ethoxyindole-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C(Cl)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 XUYLEIKOZAMWOE-UHFFFAOYSA-N 0.000 claims 1
- OCRONEAVJHGACD-UHFFFAOYSA-N 1'-(3-chloro-1-cyclopropyl-7-ethoxyindole-5-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2C(Cl)=CN1C1CC1 OCRONEAVJHGACD-UHFFFAOYSA-N 0.000 claims 1
- ZLDRXVSQRSQAOV-UHFFFAOYSA-N 1'-(3-cyclopropyl-7-ethoxy-1,2-benzoxazole-5-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound N=1OC=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2C=1C1CC1 ZLDRXVSQRSQAOV-UHFFFAOYSA-N 0.000 claims 1
- JHCULCUEXUZDTM-UHFFFAOYSA-N 1'-(3-cyclopropyl-7-methoxybenzimidazole-5-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=NC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 JHCULCUEXUZDTM-UHFFFAOYSA-N 0.000 claims 1
- GKXFKKPTSSQZNU-UHFFFAOYSA-N 1'-(3-cyclopropyl-8-methoxyimidazo[1,2-a]pyridine-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C=1N=C2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CN2C=1C1CC1 GKXFKKPTSSQZNU-UHFFFAOYSA-N 0.000 claims 1
- AFKBHASOWVCPBV-UHFFFAOYSA-N 1'-(4-acetyl-7-methoxy-1-benzofuran-2-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound O1C=2C(OC)=CC=C(C(C)=O)C=2C=C1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 AFKBHASOWVCPBV-UHFFFAOYSA-N 0.000 claims 1
- OQZSPIHVLNEMOM-UHFFFAOYSA-N 1'-(4-methoxy-1-methylpyrazolo[3,4-b]pyridine-6-carbonyl)-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound N=1C=2N(C)N=CC=2C(OC)=CC=1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 OQZSPIHVLNEMOM-UHFFFAOYSA-N 0.000 claims 1
- YWEBYUIRXNXPKJ-UHFFFAOYSA-N 1'-[1-cyclopropyl-4-(2-hydroxyethoxy)indole-6-carbonyl]-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=CC=2C(OCCO)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 YWEBYUIRXNXPKJ-UHFFFAOYSA-N 0.000 claims 1
- VIINMHDSRKGUSP-UHFFFAOYSA-N 1'-[1-ethyl-4-(2-hydroxyethoxy)indole-6-carbonyl]-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C2N(CC)C=CC2=C(OCCO)C=C1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=NN=NN1 VIINMHDSRKGUSP-UHFFFAOYSA-N 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- MMOGEKMWSXYDNU-UHFFFAOYSA-N 1-cyclopropyl-4-ethoxy-6-[4-oxo-6-(1h-pyrazol-4-yl)spiro[3h-chromene-2,4'-piperidine]-1'-carbonyl]indole-3-carboxylic acid Chemical compound C1=C(C(O)=O)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C3=CNN=C3)=CC=2N1C1CC1 MMOGEKMWSXYDNU-UHFFFAOYSA-N 0.000 claims 1
- VYYLYKNBTKXAJC-UHFFFAOYSA-N 1-cyclopropyl-4-ethoxy-6-[4-oxo-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-1'-carbonyl]indole-3-carboxamide Chemical compound C1=C(C(N)=O)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 VYYLYKNBTKXAJC-UHFFFAOYSA-N 0.000 claims 1
- BPNDISJEGZBLQJ-UHFFFAOYSA-N 1-cyclopropyl-4-ethoxy-6-[6-[(2-methylpyrazol-3-yl)amino]-4-oxospiro[3h-chromene-2,4'-piperidine]-1'-carbonyl]indole-3-carboxylic acid Chemical compound C1=C(C(O)=O)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(NC=5N(N=CC=5)C)C=C3C(=O)C4)=CC=2N1C1CC1 BPNDISJEGZBLQJ-UHFFFAOYSA-N 0.000 claims 1
- WTFVNBJKZFCVHC-UHFFFAOYSA-N 1-cyclopropyl-4-ethoxy-n-methyl-6-[4-oxo-6-(2h-tetrazol-5-yl)spiro[3h-chromene-2,4'-piperidine]-1'-carbonyl]indole-3-carboxamide Chemical compound C1=C(C(=O)NC)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NN=NN=3)=CC=2N1C1CC1 WTFVNBJKZFCVHC-UHFFFAOYSA-N 0.000 claims 1
- USCXFVCAIMZLJL-UHFFFAOYSA-N 3-[1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]-1h-1,2,4-triazole-5-carboxamide Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3NC(=NN=3)C(N)=O)=CC=2N1C1CC1 USCXFVCAIMZLJL-UHFFFAOYSA-N 0.000 claims 1
- PDAJKOILZCBVGF-UHFFFAOYSA-N 3-[1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]benzoic acid Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=CC=3)C(O)=O)=CC=2N1C1CC1 PDAJKOILZCBVGF-UHFFFAOYSA-N 0.000 claims 1
- IMNGKACLQXZBGK-UHFFFAOYSA-N 3-[1'-(3-carbamoyl-1-cyclopropyl-4-ethoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]benzoic acid Chemical compound C1=C(C(N)=O)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=CC=3)C(O)=O)=CC=2N1C1CC1 IMNGKACLQXZBGK-UHFFFAOYSA-N 0.000 claims 1
- YWTADLQQMJMIFQ-UHFFFAOYSA-N 4-[1'-(1-cyclopropyl-4-ethoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-2-carboxylic acid Chemical compound C1=C(C)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(N=CC=3)C(O)=O)=CC=2N1C1CC1 YWTADLQQMJMIFQ-UHFFFAOYSA-N 0.000 claims 1
- OIZHPXQONHLOHM-UHFFFAOYSA-N 4-[1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-2-carboxylic acid Chemical compound C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(N=CC=3)C(O)=O)=CC=2N1C1CC1 OIZHPXQONHLOHM-UHFFFAOYSA-N 0.000 claims 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 claims 1
- RUEOSAFLJXCAIN-UHFFFAOYSA-N 5-[1'-(1,4-dimethoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid Chemical compound C=1C=2N(OC)C=C(C)C=2C(OC)=CC=1C(=O)N(CC1)CCC1(OC1=CC=2)CC(=O)C1=CC=2C1=CN=CC(C(O)=O)=C1 RUEOSAFLJXCAIN-UHFFFAOYSA-N 0.000 claims 1
- APPNDGWGOXONSC-UHFFFAOYSA-N 5-[1'-(1-cyclopropyl-4-ethoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]-2-methylpyridine-3-carboxylic acid Chemical group C1=C(C)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C(C)=NC=3)C(O)=O)=CC=2N1C1CC1 APPNDGWGOXONSC-UHFFFAOYSA-N 0.000 claims 1
- WFWSTFMGVNHXSR-UHFFFAOYSA-N 5-[1'-(1-cyclopropyl-4-ethoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid Chemical compound C1=C(C)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C(O)=O)=CC=2N1C1CC1 WFWSTFMGVNHXSR-UHFFFAOYSA-N 0.000 claims 1
- JNQADECYZCNJMH-UHFFFAOYSA-N 5-[1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]-2-methylpyridine-3-carboxylic acid Chemical compound C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C(C)=NC=3)C(O)=O)=CC=2N1C1CC1 JNQADECYZCNJMH-UHFFFAOYSA-N 0.000 claims 1
- WDBNGXLHMZSUEI-UHFFFAOYSA-N 5-[1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid Chemical compound C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C(O)=O)=CC=2N1C1CC1 WDBNGXLHMZSUEI-UHFFFAOYSA-N 0.000 claims 1
- JOIYYAUZXKGMEN-UHFFFAOYSA-N 5-[1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C(O)=O)=CC=2N1C1CC1 JOIYYAUZXKGMEN-UHFFFAOYSA-N 0.000 claims 1
- ROSMZCLZFCCOAR-UHFFFAOYSA-N 5-[1'-(6-cyclopropyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)N2CCC3(CC2)OC2=CC=C(C=C2C(=O)C3)C=2C=C(C=NC=2)C(O)=O)C=C1C1CC1 ROSMZCLZFCCOAR-UHFFFAOYSA-N 0.000 claims 1
- KAZDJFUSKMFXBV-UHFFFAOYSA-N 6-(5-bromopyridin-3-yl)-1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)spiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(Br)C=NC=3)=CC=2N1C1CC1 KAZDJFUSKMFXBV-UHFFFAOYSA-N 0.000 claims 1
- CAXIHAPXMMNCES-UHFFFAOYSA-N 6-[1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid Chemical compound C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3N=CC(=CC=3)C(O)=O)=CC=2N1C1CC1 CAXIHAPXMMNCES-UHFFFAOYSA-N 0.000 claims 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 1
- HKGYUWFDBUZZGY-UHFFFAOYSA-N C1(CC1)N1C=C(C2=C(C=C(C=C12)C(=O)N1CCC2(CC1)OC1=CC=C(C=C1CC2)C2=NN=NN2)OCC)C Chemical compound C1(CC1)N1C=C(C2=C(C=C(C=C12)C(=O)N1CCC2(CC1)OC1=CC=C(C=C1CC2)C2=NN=NN2)OCC)C HKGYUWFDBUZZGY-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 claims 1
- LFEQZYUGJYUYIE-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-1'-(1,4-diethoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-carboxamide Chemical compound C1C(=O)C2=CC(C(=O)NCC(N)=O)=CC=C2OC1(CC1)CCN1C(=O)C(C=C1OCC)=CC2=C1C=CN2OCC LFEQZYUGJYUYIE-UHFFFAOYSA-N 0.000 claims 1
- CTQOCKWNBNCZNJ-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-1'-(1-cyclopropyl-4-ethoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-carboxamide Chemical compound C1=C(C)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C(=O)NCC(N)=O)=CC=2N1C1CC1 CTQOCKWNBNCZNJ-UHFFFAOYSA-N 0.000 claims 1
- MBDZVTFWDBQDGE-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-1'-(1-cyclopropyl-4-ethoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-carboxamide Chemical compound C1=CC=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C(=O)NCC(N)=O)=CC=2N1C1CC1 MBDZVTFWDBQDGE-UHFFFAOYSA-N 0.000 claims 1
- FVTARXCMBGNOLF-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-carboxamide Chemical compound C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C(=O)NCC(N)=O)=CC=2N1C1CC1 FVTARXCMBGNOLF-UHFFFAOYSA-N 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- PHRGTBNTADHMBH-UHFFFAOYSA-M sodium;4-[1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-2-carboxylate Chemical compound [Na+].C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(N=CC=3)C([O-])=O)=CC=2N1C1CC1 PHRGTBNTADHMBH-UHFFFAOYSA-M 0.000 claims 1
- ZCYIWEKNLXHNGV-UHFFFAOYSA-M sodium;5-[1'-(1-cyclopropyl-4-ethoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylate Chemical compound [Na+].C1=C(C)C=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C([O-])=O)=CC=2N1C1CC1 ZCYIWEKNLXHNGV-UHFFFAOYSA-M 0.000 claims 1
- WZGQQJLIKGPVMH-UHFFFAOYSA-M sodium;5-[1'-(1-cyclopropyl-4-ethoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylate Chemical compound [Na+].C1=CC=2C(OCC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C([O-])=O)=CC=2N1C1CC1 WZGQQJLIKGPVMH-UHFFFAOYSA-M 0.000 claims 1
- GGRZUOUSTJCEBC-UHFFFAOYSA-M sodium;5-[1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylate Chemical compound [Na+].C1=C(C)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C([O-])=O)=CC=2N1C1CC1 GGRZUOUSTJCEBC-UHFFFAOYSA-M 0.000 claims 1
- SUDMSXKBZWSKPJ-UHFFFAOYSA-M sodium;5-[1'-(1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-2-carboxylate Chemical compound [Na+].C1=CC=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=NC(=CC=3)C([O-])=O)=CC=2N1C1CC1 SUDMSXKBZWSKPJ-UHFFFAOYSA-M 0.000 claims 1
- FOTRFPZDSUQERC-UHFFFAOYSA-M sodium;5-[1'-(3-chloro-1-cyclopropyl-4-methoxyindole-6-carbonyl)-4-oxospiro[3h-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylate Chemical compound [Na+].C1=C(Cl)C=2C(OC)=CC(C(=O)N3CCC4(CC3)OC3=CC=C(C=C3C(=O)C4)C=3C=C(C=NC=3)C([O-])=O)=CC=2N1C1CC1 FOTRFPZDSUQERC-UHFFFAOYSA-M 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88030207P | 2007-01-12 | 2007-01-12 | |
| US60/880,302 | 2007-01-12 | ||
| PCT/US2008/000221 WO2008088688A1 (en) | 2007-01-12 | 2008-01-08 | Substituted spirochromanone derivatives as acc inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010515733A JP2010515733A (ja) | 2010-05-13 |
| JP2010515733A5 true JP2010515733A5 (enExample) | 2011-02-03 |
| JP5319550B2 JP5319550B2 (ja) | 2013-10-16 |
Family
ID=39297859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009545577A Expired - Fee Related JP5319550B2 (ja) | 2007-01-12 | 2008-01-08 | 置換スピロクロマノン誘導体 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8093389B2 (enExample) |
| EP (1) | EP2111406B1 (enExample) |
| JP (1) | JP5319550B2 (enExample) |
| KR (1) | KR20090108022A (enExample) |
| CN (1) | CN101631791B (enExample) |
| AR (1) | AR064824A1 (enExample) |
| AU (1) | AU2008205638B2 (enExample) |
| BR (1) | BRPI0806531A2 (enExample) |
| CA (1) | CA2674573C (enExample) |
| CL (1) | CL2008000067A1 (enExample) |
| CO (1) | CO6190611A2 (enExample) |
| CR (1) | CR10944A (enExample) |
| DO (1) | DOP2009000176A (enExample) |
| EC (1) | ECSP099503A (enExample) |
| GT (1) | GT200900194A (enExample) |
| HN (1) | HN2009001276A (enExample) |
| MA (1) | MA31108B1 (enExample) |
| MX (1) | MX2009007502A (enExample) |
| NI (1) | NI200900139A (enExample) |
| NZ (1) | NZ577825A (enExample) |
| PE (1) | PE20081559A1 (enExample) |
| RU (1) | RU2009130736A (enExample) |
| SG (1) | SG177977A1 (enExample) |
| TW (1) | TW200836727A (enExample) |
| UA (1) | UA103990C2 (enExample) |
| WO (2) | WO2008088688A1 (enExample) |
| ZA (1) | ZA200904138B (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0613427A2 (pt) * | 2005-07-19 | 2012-10-30 | Merck & Co Inc | composto ou seu sal ou éster, composição farmacêutica, agente terapêutico, e , uso do composto ou seu sal ou éster |
| AU2008205642B2 (en) * | 2007-01-12 | 2013-06-06 | Msd K.K. | Spirochromanon derivatives |
| US7946800B2 (en) | 2007-04-06 | 2011-05-24 | Brooks Automation, Inc. | Substrate transport apparatus with multiple independently movable articulated arms |
| US8267636B2 (en) | 2007-05-08 | 2012-09-18 | Brooks Automation, Inc. | Substrate transport apparatus |
| WO2009097995A1 (de) * | 2008-02-07 | 2009-08-13 | Sanofi-Aventis | Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8318762B2 (en) * | 2008-05-28 | 2012-11-27 | Pfizer Inc. | Pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
| JP5501256B2 (ja) | 2008-07-04 | 2014-05-21 | Ｍｓｄ株式会社 | 新規スピロクロマノンカルボン酸 |
| EP2310015A4 (en) * | 2008-07-14 | 2011-10-26 | Cropsolution Inc | ACETYL-COENZYME-CARBOXYLASE MODULATORS AND METHODS OF USE THEREOF |
| SG171765A1 (en) | 2008-11-20 | 2011-07-28 | Genentech Inc | Pyrazolopyridine pi3k inhibitor compounds and methods of use |
| CN102695708B (zh) * | 2009-11-10 | 2014-10-15 | 辉瑞大药厂 | N1-吡唑并螺酮乙酰辅酶a羧化酶抑制剂 |
| EP2519288B1 (en) * | 2009-12-31 | 2016-04-13 | DEKA Products Limited Partnership | Infusion pump assembley |
| US8598164B2 (en) | 2010-05-06 | 2013-12-03 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| CN101851237B (zh) * | 2010-06-18 | 2012-10-17 | 南方医科大学 | 一种螺环化合物及其制备方法和应用 |
| RS55224B1 (sr) | 2010-09-30 | 2017-02-28 | Pfizer | N1-pirazolospiroketon acetil-coa karboksilaza inhibitori |
| PT2632925E (pt) | 2010-10-29 | 2015-09-01 | Pfizer | Inibidores de n1/n2-lactama da acetil-coa carboxilase |
| WO2012077655A1 (ja) * | 2010-12-07 | 2012-06-14 | 塩野義製薬株式会社 | Ｇｐｒ１１９アゴニスト活性を有するスピロ誘導体 |
| TWI520964B (zh) | 2011-02-02 | 2016-02-11 | 維泰克斯製藥公司 | 作為離子通道調節劑之吡咯并吡－螺環哌啶醯胺 |
| AU2012217616B2 (en) | 2011-02-18 | 2017-03-02 | Vertex Pharmaceuticals Incorporated | Chroman - spirocyclic piperidine amides as modulators of ion channels |
| US8828996B2 (en) | 2011-03-14 | 2014-09-09 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
| RS54526B1 (sr) | 2011-04-22 | 2016-06-30 | Pfizer Inc. | Upotreba derivata pirazolospiroketona kao inhibitora acetil-coa karboksilaze |
| TW201300393A (zh) * | 2011-05-20 | 2013-01-01 | Kowa Co | 新穎之螺哌啶衍生物及含有其之醫藥 |
| WO2013113791A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| US9055750B2 (en) | 2012-02-03 | 2015-06-16 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113720A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113776A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113773A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| US9072301B2 (en) | 2012-02-03 | 2015-07-07 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113716A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
| HK1221662A1 (zh) | 2013-05-10 | 2017-06-09 | Gilead Apollo, Llc | Acc抑制剂和其用途 |
| MX2015015422A (es) | 2013-05-10 | 2016-06-21 | Nimbus Apollo Inc | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. |
| BR112016004118A2 (pt) | 2013-09-12 | 2017-10-17 | Pfizer | uso de inibidores da acetil-coa carboxilase para tratamento de acne vulgar |
| EP3554637A4 (en) | 2016-12-14 | 2020-05-20 | 89Bio Ltd. | SPIROPIPERID DERIVATIVES |
| CA3068623A1 (en) * | 2017-06-30 | 2019-01-03 | Quixgen, Inc. | Novel spirolactone compounds |
| IL318404A (en) * | 2022-07-29 | 2025-03-01 | Pfizer | NOVEL ACC INHIBITORS |
| CN119798270B (zh) * | 2025-01-06 | 2026-02-24 | 中国海洋大学 | 靶向egfr的小分子化合物及其应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2814983A1 (de) * | 1978-04-07 | 1979-10-18 | Bayer Ag | Neue chromanon-derivate |
| JPH03182725A (ja) | 1989-12-08 | 1991-08-08 | Internatl Business Mach Corp <Ibm> | 非線形光学素子及びその製造方法 |
| US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
| IL96507A0 (en) * | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
| NZ243065A (en) | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DE69412067T2 (de) | 1993-01-28 | 1999-03-25 | Merck & Co., Inc., Rahway, N.J. | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten |
| US5856083A (en) | 1994-05-06 | 1999-01-05 | Pharmacopeia, Inc. | Lawn assay for compounds that affect enzyme activity or bind to target molecules |
| US5688997A (en) * | 1994-05-06 | 1997-11-18 | Pharmacopeia, Inc. | Process for preparing intermediates for a combinatorial dihydrobenzopyran library |
| US6017768A (en) | 1994-05-06 | 2000-01-25 | Pharmacopeia, Inc. | Combinatorial dihydrobenzopyran library |
| CA2189634A1 (en) | 1994-05-06 | 1995-11-16 | John J. Baldwin | Combinatorial dihydrobenzopyran library |
| WO1996039140A1 (en) | 1995-06-06 | 1996-12-12 | Merck & Co., Inc. | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| GB9601724D0 (en) * | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
| GB0003397D0 (en) * | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
| WO2002020509A2 (de) | 2000-09-06 | 2002-03-14 | Bayer Aktiengesellschaft | Arzneimittel gegen virale erkrankungen |
| JP2005162612A (ja) | 2002-01-09 | 2005-06-23 | Ajinomoto Co Inc | アシルスルホンアミド誘導体 |
| JP2005170790A (ja) | 2002-01-09 | 2005-06-30 | Ajinomoto Co Inc | Ｎ−アルキルスルフォニル置換アミド誘導体 |
| EP1478437B1 (en) | 2002-02-27 | 2005-08-31 | Pfizer Products Inc. | Acc inhibitors |
| JP2005320250A (ja) | 2002-05-09 | 2005-11-17 | Ajinomoto Co Inc | ビスラクトン誘導体及びその医薬組成物としての使用 |
| AU2003299791A1 (en) | 2002-12-20 | 2004-07-22 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| WO2004092179A1 (ja) | 2003-04-14 | 2004-10-28 | Nippon Soda Co. Ltd. | スピロ誘導体、製造法および抗酸化薬 |
| FR2856685B1 (fr) | 2003-06-25 | 2005-09-23 | Merck Sante Sas | Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2005119987A (ja) | 2003-10-15 | 2005-05-12 | Ajinomoto Co Inc | アシルスルホンアミド誘導体 |
| EP1802623A1 (en) * | 2004-10-12 | 2007-07-04 | Novo Nordisk A/S | 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| BRPI0518281A2 (pt) | 2004-11-18 | 2008-11-18 | Incyte Corp | inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos |
| US20090215742A1 (en) | 2005-05-03 | 2009-08-27 | Pfizer, Inc. | Amide resorcinol compounds |
| BRPI0613427A2 (pt) * | 2005-07-19 | 2012-10-30 | Merck & Co Inc | composto ou seu sal ou éster, composição farmacêutica, agente terapêutico, e , uso do composto ou seu sal ou éster |
| AU2007326950B2 (en) * | 2006-11-29 | 2010-10-14 | Pfizer Products Inc. | Spiroketone acetyl-CoA carboxylase inhibitors |
| AU2008205642B2 (en) * | 2007-01-12 | 2013-06-06 | Msd K.K. | Spirochromanon derivatives |
-
2008
- 2008-01-04 PE PE2008000089A patent/PE20081559A1/es not_active Application Discontinuation
- 2008-01-07 TW TW097100608A patent/TW200836727A/zh unknown
- 2008-01-08 JP JP2009545577A patent/JP5319550B2/ja not_active Expired - Fee Related
- 2008-01-08 US US12/007,000 patent/US8093389B2/en active Active
- 2008-01-08 MX MX2009007502A patent/MX2009007502A/es unknown
- 2008-01-08 CA CA2674573A patent/CA2674573C/en not_active Expired - Fee Related
- 2008-01-08 UA UAA200908468A patent/UA103990C2/ru unknown
- 2008-01-08 SG SG2012002739A patent/SG177977A1/en unknown
- 2008-01-08 WO PCT/US2008/000221 patent/WO2008088688A1/en not_active Ceased
- 2008-01-08 CN CN2008800021443A patent/CN101631791B/zh not_active Expired - Fee Related
- 2008-01-08 NZ NZ577825A patent/NZ577825A/en not_active IP Right Cessation
- 2008-01-08 KR KR1020097014377A patent/KR20090108022A/ko not_active Withdrawn
- 2008-01-08 WO PCT/US2008/000223 patent/WO2008088689A1/en not_active Ceased
- 2008-01-08 AU AU2008205638A patent/AU2008205638B2/en not_active Ceased
- 2008-01-08 BR BRPI0806531-4A2A patent/BRPI0806531A2/pt not_active IP Right Cessation
- 2008-01-08 RU RU2009130736/04A patent/RU2009130736A/ru not_active Application Discontinuation
- 2008-01-08 EP EP08713050A patent/EP2111406B1/en active Active
- 2008-01-09 AR ARP080100081A patent/AR064824A1/es not_active Application Discontinuation
- 2008-01-10 CL CL200800067A patent/CL2008000067A1/es unknown
-
2009
- 2009-06-12 ZA ZA200904138A patent/ZA200904138B/xx unknown
- 2009-07-06 GT GT200900194A patent/GT200900194A/es unknown
- 2009-07-06 HN HN2009001276A patent/HN2009001276A/es unknown
- 2009-07-08 NI NI200900139A patent/NI200900139A/es unknown
- 2009-07-09 EC EC2009009503A patent/ECSP099503A/es unknown
- 2009-07-09 DO DO2009000176A patent/DOP2009000176A/es unknown
- 2009-07-13 CO CO09072490A patent/CO6190611A2/es active IP Right Grant
- 2009-07-20 CR CR10944A patent/CR10944A/es unknown
- 2009-07-23 MA MA32114A patent/MA31108B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010515733A5 (enExample) | ||
| JP2010515734A5 (enExample) | ||
| RU2009130736A (ru) | Замещенные производные спирохроманона | |
| AU2016358242B2 (en) | N-substituted indole derivatives as PGE2 receptor modulators | |
| RU2016140338A (ru) | Азаспиро производные в качестве антагонистов trpm8 | |
| JP5271917B2 (ja) | スピロクロマノン誘導体 | |
| JP5331693B2 (ja) | 新規置換ビピリジン誘導体およびアデノシン受容体リガンドとしてのそれらの使用 | |
| KR102398473B1 (ko) | Tam 패밀리 키나제 억제제로서의 아미노피리딘 유도체 | |
| HRP20231310T1 (hr) | Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene | |
| BG107899A (bg) | Б...нзимидазолови и пиридилимидазолови производни ка'о лиганди на gaba р...-...п'ори | |
| HRP20120174T1 (hr) | Derivat policikličnog cinamida | |
| JPWO2020231808A5 (enExample) | ||
| JP2012532931A5 (enExample) | ||
| ES2550201T3 (es) | Moduladores de la PDE10 | |
| JP2013540119A5 (enExample) | ||
| CA2959501A1 (en) | Probes for imaging huntingtin protein | |
| AU2013286894A1 (en) | Heterocyclic modulators of lipid synthesis | |
| RU2008106243A (ru) | Производные спирохроманона в качестве ингибиторов ацетил коэнзим а карбоксилазы (асс) | |
| JP2021501220A5 (enExample) | ||
| JP2018534328A5 (enExample) | ||
| SI2763982T1 (en) | Substituted benzylindazoles for use as inhibitors of Bub kinase in the treatment of hyperproliferative diseases | |
| JP2011516512A5 (ja) | 新規な置換スピロ[シクロアルキル−１,３'−インドール]−２'(１'Ｈ)−オン誘導体およびｐ３８マイトジェン活性化タンパク質キナーゼ阻害剤としてのそれらの使用 | |
| AU2005301608B2 (en) | Aryloxy-substituted benzimidazole derivatives | |
| JP2014504300A5 (enExample) | ||
| JP2011520915A5 (enExample) |